US11154572B2

Methods of treatment with natural killer cells matched for killer …

University of Texas System

Abstract

The present invention concerns methods of treating a disease such as leukemia in a subject by administering natural killer (NK) cells. In particular aspects, HLA-C1-licensed KIR2DL2/3 and KIR2DS2 NK cells are administered to a subject with an HLA-C genotype either homozygous or heterozygous for …

University: University of Texas System
Assignee: Board Of Regents, The University Of Texas System
Inventor: Katy REZVANI
Priority date: June 05, 2015
Filing date: June 06, 2016
Grant date: October 26, 2021
Publication date: October 26, 2021
Language: en
PDF source: https://patentimages.storage.googleapis.com/92/f4/0a/6d5e149ef77345/US11154572.pdf
Metadata fetched: August 29, 2026 00:27